Related Experiment Videos
Components of the alternative pathway of complement in otitis media with effusion
Abstract:
An evaluation of the alternative pathway of complement was undertaken in patients with otitis media with effusion (OME). Middle ear fluid (MEF) and serum specimens were obtained from 34 patients at the time of elective myringotomy for OME. Bacterial, viral, and mycoplasma cultures were made for all specimens of the fluids. Immunochemical determinations by radial immunodiffusion were performed for C3, C5, factor B, properdin, factor H, factor I, and albumin. Each patient's recent clinical course and past history were reviewed. The results of all viral and mycoplasma cultures were negative. Three of 55 bacterial cultures were positive for type B Haemophilus influenzae. All components of the alternative pathway measured were found to be present in varying amounts in MEF. When the levels of the complement components were compared to the clinical factors studied, there were no observable differences. These data suggest that components of the alternative pathway of complement are present in OME and are not useful in predicting the clinical course or outcome of this disorder.
Insights
Components of the alternative pathway of complement are present in middle ear fluid (MEF) from patients with otitis media with effusion (OME). However, these complement levels do not predict the clinical course or outcome of OME.
Area of Science:
- Immunology
- Otolaryngology
- Molecular Biology
Background:
- Otitis media with effusion (OME) is a common condition in children.
- The role of the complement system, particularly the alternative pathway, in OME pathogenesis is not fully understood.
- Understanding complement involvement may offer insights into OME management.
Purpose of the Study:
- To evaluate the presence and levels of alternative pathway complement components in middle ear fluid (MEF) of OME patients.
- To determine if these complement levels correlate with clinical factors or predict OME outcomes.
- To investigate the potential role of bacterial infections in complement activation.
Main Methods:
- Collected middle ear fluid (MEF) and serum from 34 patients undergoing myringotomy for OME.
- Performed bacterial, viral, and mycoplasma cultures on MEF.
- Quantified complement components (C3, C5, factor B, properdin, factor H, factor I) and albumin in MEF and serum using radial immunodiffusion.
- Reviewed patient clinical history and recent course.
Main Results:
- Viral and mycoplasma cultures were negative; only three bacterial cultures showed *Haemophilus influenzae* type B.
- All measured alternative pathway complement components were detected in MEF at varying concentrations.
- No significant correlation was found between complement component levels and clinical factors or patient history.
- Complement levels in MEF did not predict the clinical course or outcome of OME.
Conclusions:
- The alternative pathway of complement is active in the middle ear environment during OME.
- The presence and levels of these complement components are not useful biomarkers for predicting OME prognosis.
- Further research may be needed to explore other inflammatory mediators in OME.